The Endocannabinoid System as a Target for the Treatment of Visceral Obesity and Metabolic Syndrome

@article{Kyrou2006TheES,
  title={The Endocannabinoid System as a Target for the Treatment of Visceral Obesity and Metabolic Syndrome},
  author={Ioannis Kyrou and George Valsamakis and Constantine Tsigos},
  journal={Annals of the New York Academy of Sciences},
  year={2006},
  volume={1083}
}
Abstract:  The endogenous cannabinoid system is a novel, remarkably elaborate physiological signaling system, comprising the recently identified endogenous cannabinoid ligands, their corresponding selective receptors, and the machinery of proteins and enzymes that is involved in their biosynthesis, release, transport, and degradation. This system extends widely in both the central nervous system (CNS) and the periphery and exhibits a variety of actions implicated in vital functions (e.g… 
View on Wiley
ncbi.nlm.nih.gov
32 Citations
Highly Influential Citations
1
Background Citations
7

32 Citations

CB1 receptor antagonism: biological basis for metabolic effects

The Endocannabinoid System as a Novel Approach for Managing Obesity

  • J. Lillo
  • Medicine, Biology
    The Journal of the American Osteopathic Association
  • 2007
Rimonabant is the first cannabinoid receptor 1 antagonist to be marketed in Europe and the first to file an New Drug Application in the United States and may provide a novel therapeutic strategy for the treatment of patients with obesity and associated cardiometabolic risk factors.

Prospective therapeutic agents for obesity: molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists.

The challenge of treating obesity: the endocannabinoid system as a potential target.

Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity.

These adrenocortical perturbations contribute to the development of metabolic syndrome at both the paracrine and systemic level by favoring the physiological dysregulation of organs responsive to aldosterone, GC, and/or androgens, including adipose tissue.

Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: efficacy.

Cannabinoids in Eating Disorders and Obesity

Genetic studies on this system in eating disorders and obesity and studies locating cannabinoid receptors in areas related to food intake suggest cannabinoid hyperactivity in obesity, and this excessive activity may have prognostic implications.

18β-glycyrrhetinic acid attenuates anandamide-induced adiposity and high-fat diet induced obesity.

Results may provide a novel insight into the molecular mechanism involved in anti-adipogenic and anti-obesity effects of 18β-GA by suppressing the activation of CB1R induced by AEA and may exert beneficial effects against obesity-related metabolic disorders.

Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice

Rimonabant decreased lipopolysaccharide (LPS)- and IL1&bgr;-induced proinflammatory gene expression in mouse peritoneal macrophages in vitro as well as thioglycollate-induced recruitment of macrophage in vivo (10 mg/kg, po bolus).

The Effect of Gender and Rimonabant on Energy Expenditure, Gene Expression and Body Fat Distribution in Obesity.

It was demonstrated, for the first time in humans, that treatment with rimonabant, whilst daily energy intake was maintained at pre-treatment levels, still induced weight loss and reinforced that the endocannabinoid system is a good potential target in the treatment of obesity.

References

SHOWING 1-10 OF 131 REFERENCES

The emerging role of the endocannabinoid system in endocrine regulation and energy balance.

The ability of the endocannabinoid system to control appetite, food intake, and energy balance has recently received great attention, particularly in the light of the different modes of action underlying these functions.

Food for thought: endocannabinoid modulation of lipogenesis.

A report in this issue of the JCI demonstrates the presence of a common endocannabinoid-regulated molecular pathway for peripheral lipogenic and central appetitive regulation in the liver and hypothalamus.

Endocannabinoids in the central nervous system--an overview.

  • E. Fride
  • Biology, Chemistry
    Prostaglandins, leukotrienes, and essential fatty acids
  • 2002
The role of the endocannabinoid system in appetite stimulation in the adult organism, and perhaps more importantly, its critical involvement in milk ingestion and survival of the newborn, may not only further the understanding of the physiology of food intake and growth, but may also find therapeutic applications in wasting disease and infant's "failure to thrive".

The endocannabinoid system: a general view and latest additions

The latest ‘additions’ to the endocannabinoid system are reviewed together with earlier breakthroughs that have contributed to the present knowledge of the biochemistry and pharmacology of theendocannabinoids.

Endocannabinoids in the regulation of appetite and body weight

  • T. Kirkham
  • Biology, Medicine
    Behavioural pharmacology
  • 2005
It is now confirmed that endocannabinoids, acting at brain CB1 cannabinoid receptors, stimulate appetite and ingestive behaviours, partly through interactions with more established orexigenic and anorexigenic signals.

Endogenous cannabinoid system as a modulator of food intake

The aim of this review is to provide an extensive overview on the role of this neuromodulatory system in feeding behavior by summarizing the most relevant data obtained from human and animal studies and by elucidating the interactions of the cannabinoid system with the most important neuronal networks and metabolic pathways involved in the control of food intake.

Analysis of the endocannabinoid system by using CB1 cannabinoid receptor knockout mice.

This chapter reviews the main results obtained with these lines of CB1 knockout mice in several physiological responses that have been previously related to the activity of the endocannabinoid system and provides an update of the apparently controversial data reported in the literature.

Activation of the peripheral endocannabinoid system in human obesity.

The findings support the presence of a peripheral endocannabinoid system that is upregulated in human obesity and increased in mature human adipocytes compared with in preadipocytes and was found in several human tissues.

Central and Peripheral Signaling Mechanisms Involved in Endocannabinoid Regulation of Feeding: A Perspective on the Munchies

The endocannabinoid system is a critical regulator of energy homeostasis and food intake both by modulating the inputs to various brain areas that monitor energy balance and by increasing the hedonic or reward value of the food consumed.

Molecular characterization of a peripheral receptor for cannabinoids

The cloning of a receptor for cannabinoids is reported that is not expressed in the brain but rather in macrophages in the marginal zone of spleen, which helps clarify the non-psychoactive effects of cannabinoids.
...